靶向于非小细胞肺癌的肿瘤新生血管
Targeting tumor neovasculature in non-small-cell lung cancer
Article Outline
- Abstract
- 1. Introduction
- 2. Tumor angiogenesis
- 3. Monoclonal antibodies
- 3.1. Bevacizumab
- 3.2. AVE0005 (VEGF-trap)
- 4. VEGF-receptors tyrosine kinase inhibitors
- 4.1. Sorafenib
- 4.2. Sunitinib
- 4.3. Pazopanib
- 4.4. Cediranib
- 4.5. BIBF 1120
- 4.6. Axitinib
- 4.7. Motesanib
- 5. Vascular disrupting agents (VDAs)
- 5.1. Vadimezan (ASA404)
- 5.2. ABT-751
- 6. Inhibition of multiple pathways
- 7. Biomarkers of response to antiangiogenic treatment
- 7.1. Blood pressure
- 7.2. VEGF as
学科代码:肿瘤学 关键词:Angiogenesis NSCLC VEGF VEGFR Bevacizumab
来源: Critical Reviews In Oncology Hematology顶一下(0)
- 您可能感兴趣的文章
-